327 related articles for article (PubMed ID: 22227230)
41. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
[TBL] [Abstract][Full Text] [Related]
42. Combination of Adt-O1Manisa and Ad5-boIFNλ3 induces early protective immunity against foot-and-mouth disease in cattle.
Diaz-San Segundo F; Montiel NA; Sturza DF; Perez-Martin E; Hickman D; Ramirez-Medina E; Grubman MJ; de Los Santos T
Virology; 2016 Dec; 499():340-349. PubMed ID: 27743960
[TBL] [Abstract][Full Text] [Related]
43. Generation of Replication Deficient Human Adenovirus 5 (Ad5) Vectored FMD Vaccines.
Medina GN; de Los Santos T; Díaz-San Segundo F
Methods Mol Biol; 2022; 2465():155-175. PubMed ID: 35118621
[TBL] [Abstract][Full Text] [Related]
44. The Foot-and-Mouth Disease Carrier State Divergence in Cattle.
Stenfeldt C; Eschbaumer M; Rekant SI; Pacheco JM; Smoliga GR; Hartwig EJ; Rodriguez LL; Arzt J
J Virol; 2016 Jul; 90(14):6344-64. PubMed ID: 27147736
[TBL] [Abstract][Full Text] [Related]
45. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
Yao Q; Qian P; Huang Q; Cao Y; Chen H
J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
[TBL] [Abstract][Full Text] [Related]
46. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
[TBL] [Abstract][Full Text] [Related]
47. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
[TBL] [Abstract][Full Text] [Related]
48. Pathogenesis and micro-anatomic characterization of a cell-adapted mutant foot-and-mouth disease virus in cattle: Impact of the Jumonji C-domain containing protein 6 (JMJD6) and route of inoculation.
Lawrence P; Pacheco J; Stenfeldt C; Arzt J; Rai DK; Rieder E
Virology; 2016 May; 492():108-17. PubMed ID: 26914509
[TBL] [Abstract][Full Text] [Related]
49. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.
de Avila Botton S; Brum MC; Bautista E; Koster M; Weiblen R; Golde WT; Grubman MJ
Vaccine; 2006 Apr; 24(17):3446-56. PubMed ID: 16522345
[TBL] [Abstract][Full Text] [Related]
50. Pathogenesis of Primary Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Vaccinated and Non-Vaccinated Cattle.
Stenfeldt C; Eschbaumer M; Pacheco JM; Rekant SI; Rodriguez LL; Arzt J
PLoS One; 2015; 10(11):e0143666. PubMed ID: 26599543
[TBL] [Abstract][Full Text] [Related]
51. An alternate delivery system improves vaccine performance against foot-and-mouth disease virus (FMDV).
Pandya M; Pacheco JM; Bishop E; Kenney M; Milward F; Doel T; Golde WT
Vaccine; 2012 Apr; 30(20):3106-11. PubMed ID: 22387223
[TBL] [Abstract][Full Text] [Related]
52. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
Brehm KE; Kumar N; Thulke HH; Haas B
Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
[TBL] [Abstract][Full Text] [Related]
53. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
54. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
55. Prospects, including time-frames, for improved foot and mouth disease vaccines.
Grubman MJ; Mason PW
Rev Sci Tech; 2002 Dec; 21(3):589-600. PubMed ID: 12523699
[TBL] [Abstract][Full Text] [Related]
56. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.
Moraes MP; de Los Santos T; Koster M; Turecek T; Wang H; Andreyev VG; Grubman MJ
J Virol; 2007 Jul; 81(13):7124-35. PubMed ID: 17459931
[TBL] [Abstract][Full Text] [Related]
57. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
Fowler VL; Knowles NJ; Paton DJ; Barnett PV
Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
[TBL] [Abstract][Full Text] [Related]
58. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
59. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs.
Mayr GA; O'Donnell V; Chinsangaram J; Mason PW; Grubman MJ
Vaccine; 2001 Feb; 19(15-16):2152-62. PubMed ID: 11228388
[TBL] [Abstract][Full Text] [Related]
60. Detection of carriers of foot-and-mouth disease virus among vaccinated cattle.
Moonen P; Jacobs L; Crienen A; Dekker A
Vet Microbiol; 2004 Nov; 103(3-4):151-60. PubMed ID: 15504586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
